✦ LIBER ✦

Interleukin-2 Based Home Therapy of Metastatic Renal Cell Carcinoma: Risks and Benefits in 215 Consecutive Single Institution Patients

✍ Scribed by Hanninen, Enrique Lopez; Kirchner, Hartmut; Atzpodien, Jens

Book ID: 123440109
Publisher: Lippincott Williams and Wilkins
Year: 1996
Tongue: English
Weight: 647 KB
Volume: 155
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(01)66527-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYTOREDUCTIVE SURGERY BEFORE HIGH DOSE I

CYTOREDUCTIVE SURGERY BEFORE HIGH DOSE INTERLEUKIN-2 BASED THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

✍ Walther, McClellan M.; Yang, James C.; Pass, Harvey I.; Linehan, W. Marston; Ros 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 499 KB

Thirteen-year, long-term efficacy of int

Thirteen-year, long-term efficacy of interferon 2α and interleukin 2-based home therapy in patients with advanced renal cell carcinoma

✍ Jens Atzpodien; Reinhard Hoffmann; Marcus Franzke; Christian Stief; Thomas Wande 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Background: The goal of the current report was to demonstrate the long-term efficacy of outpatient subcutaneous (sc) interferon alpha (ifn-alpha) and sc interleukin 2 (il-2)-based combination regimens in patients with metastatic renal cell carcinoma. ## Methods: In three consecutive clinical t

The effect of low-dose interleukin-2-bas

The effect of low-dose interleukin-2-based immunotherapy on salivary function and composition in patients with metastatic renal cell carcinoma

✍ Rafael M. Nagler; Eliyahu Gez; Rafael Rubinov; Dov Laufer; Hanna Ben-Aryeh; Dian 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 73 KB

C-REACTIVE PROTEIN: A BIOMARKER OF SURVI

C-REACTIVE PROTEIN: A BIOMARKER OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUBCUTANEOUS INTERLEUKIN-2 BASED IMMUNOTHERAPY

✍ CASAMASSIMA, ADDOLORATA; PICCIARIELLO, MARGHERITA; QUARANTA, MICHELE; BERARDINO, 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 75 KB

RE: C-REACTIVE PROTEIN: A BIOMARKER OF S

RE: C-REACTIVE PROTEIN: A BIOMARKER OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUBCUTANEOUS INTERLEUKIN-2 BASED IMMUNOTHERAPY

✍ Ramsey, Sara; Aitchison, Michael 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 59 KB

Cytotoxic In vitro function in patients

Cytotoxic In vitro function in patients with metastatic renal cell carcinoma before and after alpha-2b-interferon therapy effects of activation with recombinant interleukin-2

✍ Cristina Feruglio; Renato Zambello; Livio Trentin; Pietro Bulian; Tiziano France 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB